Outset Medical, Inc. Revenue
Outset Medical, Inc. (OM) reported Revenue of $31.64 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-06
- Outset Medical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $31.64M, a 0.69% increase year-over-year.
- Outset Medical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $27.86M, a 6.35% decline year-over-year.
- Outset Medical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $28.87M, a 2.01% decline year-over-year.
- Outset Medical, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $29.43M, a 2.67% increase year-over-year.
- Outset Medical, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $119.48M, a 5.09% increase from fiscal 2024.
- Outset Medical, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $113.69M, a 12.80% decline from fiscal 2023.
- Outset Medical, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $130.38M, a 13.00% increase from fiscal 2022.
- Outset Medical, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $115.38M, a 12.45% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $31.64M 10-Q · filed 2026-08-06 | $59.50M 10-Q · filed 2026-08-06 | $88.37M derived: sum of 3 quarters · filed 2026-08-06 | $117.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $27.86M 10-Q · filed 2026-05-07 | $56.74M derived: sum of 2 quarters · filed 2026-05-07 | $86.17M derived: sum of 3 quarters · filed 2026-05-07 | $117.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $28.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $58.30M derived: sum of 2 quarters · filed 2026-02-13 | $89.72M derived: sum of 3 quarters · filed 2026-08-06 | $119.48M 10-K · filed 2026-02-13 |
| 2025-09-30 | $29.43M 10-Q · filed 2025-11-10 | $60.85M derived: sum of 2 quarters · filed 2026-08-06 | $90.60M 10-Q · filed 2025-11-10 | $120.07M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $31.42M 10-Q · filed 2026-08-06 | $61.17M 10-Q · filed 2026-08-06 | $90.64M derived: sum of 3 quarters · filed 2026-08-06 | $119.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $29.75M 10-Q · filed 2026-05-07 | $59.22M derived: sum of 2 quarters · filed 2026-05-07 | $87.89M derived: sum of 3 quarters · filed 2026-05-07 | $115.27M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $29.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $58.13M derived: sum of 2 quarters · filed 2026-02-13 | $85.52M derived: sum of 3 quarters · filed 2026-02-13 | $113.69M 10-K · filed 2026-02-13 |
| 2024-09-30 | $28.67M 10-Q · filed 2025-11-10 | $56.05M derived: sum of 2 quarters · filed 2025-11-10 | $84.22M 10-Q · filed 2025-11-10 | $114.73M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $27.39M 10-Q · filed 2025-08-07 | $55.56M 10-Q · filed 2025-08-07 | $86.06M derived: sum of 3 quarters · filed 2026-02-13 | $116.42M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $28.17M 10-Q · filed 2025-05-08 | $58.67M derived: sum of 2 quarters · filed 2026-02-13 | $89.04M derived: sum of 3 quarters · filed 2026-02-13 | $125.08M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $30.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $60.87M derived: sum of 2 quarters · filed 2026-02-13 | $96.91M derived: sum of 3 quarters · filed 2026-02-13 | $130.38M 10-K · filed 2026-02-13 |
| 2023-09-30 | $30.36M 10-Q · filed 2024-11-07 | $66.40M derived: sum of 2 quarters · filed 2024-11-07 | $99.87M 10-Q · filed 2024-11-07 | $131.88M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $36.04M 10-Q · filed 2024-08-08 | $69.51M 10-Q · filed 2024-08-08 | $101.51M derived: sum of 3 quarters · filed 2025-02-28 | $129.28M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $33.47M 10-Q · filed 2024-05-09 | $65.47M derived: sum of 2 quarters · filed 2025-02-28 | $93.23M derived: sum of 3 quarters · filed 2025-02-28 | $118.29M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $32.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $59.77M derived: sum of 2 quarters · filed 2025-02-28 | $84.83M derived: sum of 3 quarters · filed 2025-02-28 | $115.38M 10-K · filed 2025-02-28 |
| 2022-09-30 | $27.76M 10-Q · filed 2023-11-08 | $52.82M derived: sum of 2 quarters · filed 2023-11-08 | $83.37M 10-Q · filed 2023-11-08 | $111.52M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $25.06M 10-Q · filed 2023-08-03 | $55.61M 10-Q · filed 2023-08-03 | $83.76M derived: sum of 3 quarters · filed 2024-02-21 | $110.08M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $30.55M 10-Q · filed 2023-05-04 | $58.70M derived: sum of 2 quarters · filed 2024-02-21 | $85.02M derived: sum of 3 quarters · filed 2024-02-21 | $110.24M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $28.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $54.47M derived: sum of 2 quarters · filed 2024-02-21 | $79.69M derived: sum of 3 quarters · filed 2024-02-21 | $102.60M 10-K · filed 2024-02-21 |
| 2021-09-30 | $26.32M 10-Q · filed 2022-11-09 | $51.53M derived: sum of 2 quarters · filed 2022-11-09 | $74.45M 10-Q · filed 2022-11-09 | $91.70M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $25.22M 10-Q · filed 2022-08-02 | $48.13M 10-Q · filed 2022-08-02 | $65.38M derived: sum of 3 quarters · filed 2022-08-02 | $79.14M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $22.92M 10-Q · filed 2022-05-05 | $40.16M derived: sum of 2 quarters · filed 2022-05-05 | $53.92M derived: sum of 3 quarters · filed 2022-05-05 | $65.66M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $17.25M 10-K · filed 2021-03-22 | $31.00M derived: sum of 2 quarters · filed 2021-11-04 | $42.74M derived: sum of 3 quarters · filed 2021-11-04 | $49.94M 10-K · filed 2023-02-13 |
| 2020-09-30 | $13.76M 10-Q · filed 2021-11-04 | $25.50M derived: sum of 2 quarters · filed 2021-11-04 | $32.69M 10-Q · filed 2021-11-04 | $39.77M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $11.74M 10-Q · filed 2021-08-06 | $18.93M 10-Q · filed 2021-08-06 | $26.02M derived: sum of 3 quarters · filed 2021-08-06 | $28.65M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $7.19M 10-Q · filed 2021-05-06 | $14.28M derived: sum of 2 quarters · filed 2021-05-06 | $16.91M derived: sum of 3 quarters · filed 2021-05-06 | $19.78M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $7.08M 10-K · filed 2021-03-22 | $9.71M derived: sum of 2 quarters · filed 2021-03-22 | $12.59M derived: sum of 3 quarters · filed 2021-03-22 | $15.08M 10-K · filed 2022-02-23 |
| 2019-09-30 | $2.63M 10-K · filed 2021-03-22 | $5.50M derived: sum of 2 quarters · filed 2021-03-22 | $7.99M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $2.87M 10-K · filed 2021-03-22 | $5.36M derived: sum of 2 quarters · filed 2021-03-22 | ||
| 2019-03-31 | $2.49M 10-K · filed 2021-03-22 | |||
| 2018-12-31 | $2.01M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |